期刊文献+

三联疗法根除幽门螺杆菌治疗对肠道微生态的影响 被引量:3

Effect of eradicating Hp on the intestinal microecosystem
原文传递
导出
摘要 目的 探讨抗幽门螺杆菌 (Hp)治疗对患者肠道菌群状态 (肠道微生态 )及耐药性的影响。方法 分别称取 6 0例患者治疗前后新鲜粪便 0 .5 g ,选择肠道菌群中具代表性的 4种需氧菌和 6种厌氧菌分别进行需氧和厌氧培养 ,从培养出的菌落中挑选相同的菌株进行治疗前后药敏试验。结果  ( 1)治疗后肠道菌群中肠杆菌、葡萄球菌、拟杆菌、双歧杆菌、消化球菌、梭菌、乳杆菌、真杆菌均较治疗前明显降低 (P <0 .0 5 ) ;( 2 )治疗后肠道菌群中大肠埃希氏菌、消化链球菌、赛氏葡萄球菌、普氏梭杆菌、肺炎致病性链球菌群、产气真杆菌等对庆大霉素、红霉素、环丙沙星、特美丁、头孢噻肟钠等药耐药率明显增加 ,且存在多重耐药 (P <0 .0 5 ) ;( 3)治疗后超广谱 β 内酰氨酶阳性的消化链球菌、表皮葡萄球菌、普氏梭杆菌、肺炎致病性链球菌群、赛氏葡萄球菌等较治疗前分别增加 2 6 .2 %、33 .3 %、2 8.6 %、35 .3 %、2 8.6 %。结论 三联抗Hp治疗后肠道菌群失调、耐药菌株的增加、传播与扩散对广大人群存在潜在危险。 Objective To study the effect of eradicating Helicobacter pylori (Hp) on the intestinal flora behavior and the antimicrobial resistance of bacteria.Methods The fresh stool specimens of 60 patients with positive Hp were collected before and after the eradicating treatment. Four aerobes and six anaerobes representing the intestinal flora were cultivated for antimicrobial sensitive test.Results (1) The population of Enterobacterium,Peptococcus, Staphylococcus, Fusobacterium, Bacteroides, Lactobacillus, Eubacterium and Bifid bacterium were decreased after the treatment(P<0.05). (2) The antimicrobial resistance of Escherichia coli, Peptostreptococcu, S. sciuri, F.prausnitzii, S.pneumo/virgrp and E.aerofaciens to gentamicin, erythromycin, ciprofloxacin, ticar/clavulanic acid and cefotaxime increased after the treatment(P<0.05). (3) The positive rates of β-Lactamase in Peptostreptococcu, Staph.Epidermidis, Fuso.Prausnitzii, Str.Pneumo/Virgrp and Staph.Sciuri had been stepped-up about 26.2%, 33.3%, 28.6%, 35.3% and 28.6%, respectively.Conclusion A potential danger of the intestinal dysbacteriosis, diffusion and transmission of the antimicrobial resistance strains might be resulted from the eradicating Hp.
出处 《临床内科杂志》 CAS 北大核心 2003年第2期69-71,共3页 Journal of Clinical Internal Medicine
关键词 幽门螺杆菌感染 肠道微生态 菌群状态 耐药性 三联疗法 治疗 影响 Helicobacter pylori infection/treatment Intestinal microecosystem Antimicrobial resistance
  • 相关文献

参考文献1

  • 1康白 主编.正常肠道菌群与健康:第1卷:第1版[M].上海:上海科技出版社,1985.64.

同被引文献38

  • 1楼金玗,黄晓磊,陈洁.抗幽门螺杆菌感染治疗后患儿肠道菌群的变化[J].中国实用儿科杂志,2007,22(1):43-46. 被引量:9
  • 2Konturek P C, Konturek S J, Brzozowski T. Helicobacter pylori infection in gastric cancerogenesis[J]. Journal of Physiology and Pharmacology, 2009, 60(3): 3-21.
  • 3Ford A C, Forman D, Hunt R H, et al. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatie infected individuals: Systematic review and meta-analysis of randomised controlled trials[J]. BMJ-British Medical Journal, 2014, 348: g3174.
  • 4Shmuely H, Passaro D, Figer A, et al. Relationship between Helicobacter pylori CagA status and calorectal cancer[J]. American Journal of Gastroenterology, 2001, 96(12): 3406-3410.
  • 5Epplein M, Pawlita M, Michel A, et al. Helicobacter pylori protein- specific antibodies and risk of colorectal cancer[J]. Cancer Epidemiology Biomarkers & Prevention, 2013, 22(11): 1964-1974.
  • 6Nagano I, Kunishima M, Itoh Y, et al. Detection of verotoxin-producing Escherichia coli 0157:H7 by multiplex polymerase chain reaction[J]. Microbiology and Immunology, 1998, 42(5): 371-376.
  • 7van der Waaij D, Berghuis-de Vries J M, Lekkerkerk L-v. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice[J]. Journal of Hygiene (Lond), 1971, 69(3): 405-411.
  • 8Louis P, Hold G L, Flint H J. The gut mierobiota, bacterial metabolites and colorectal cancer[J]. Nature Reviews Microbiology, 2014, 12(10): 661-672.
  • 9Zhu Q, Gao R, Wu W, et al. The role of gut microbiota in the pathogenesis of colorectal cancer[J]. Tumor Biology, 2013, 34(3): 1285-1300.
  • 10Ray K. Gut microbiota: Colorectal cancer-driven by inflammation and gut bacteria?[J]. Nature Reviews Gastroenterology & Hepatology, 2012, 9(10): 558.

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部